- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06639217
Comprehensive Nursing Care Protocol for Women With Pelvic Organ Prolapse and Urinary Incontinence: A Global Perspective (Nurse Protocol)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Al Dakahlia,
-
Mansoura, Al Dakahlia,, Egypt, 35931
- Basma
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
All available nurses assigned for bed side care in the previous study settings and fulfilled the following inclusion criteria:
- Age 20≥ 60 years
- Willing to participate in the study
- Both sex
Exclusion Criteria:
- nurses did not assign for bed side care in the previous study settings and not fulfill the inclusion criteria
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: a comprehensive nursing care protocol
a comprehensive nursing care protocol provided for nurses who provide direct care for women with pelvic organ prolapse and urinary incontinence on their knowledge and practices as well as its impact on the women quality of life
|
a comprehensive nursing care protocol provided for nurses who provide direct care for women with pelvic organ prolapse and urinary incontinence on their knowledge and practices as well as its impact on the women quality of life
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Nurses knowledge structured interview
Time Frame: 3 months
|
two main parts. Part I: Lifestyle interventions: This part will be including items related to weight loss, reducing exacerbating activities (e.g. heavy lifting, coughing) and treating constipation, pelvic floor muscle exercises etc.) Part II: pessaries intervention: This part will be including items related to indication of pessaries use, pessary maintenance and follow-up, complications, various types of pessaries, etc.) The scoring system. This tool will be scored on 2 point Likert scale . The researcher will give (1) point for each correct answer and (0) point for each incorrect answer, or don't know. Total knowledge score will be summed, transferred to percent and categorized as follows:
|
3 months
|
|
Nurses Observational Practices Checklist
Time Frame: 3 months
|
This tool will be scored on 4 point Likert scale for each item as follows:
|
3 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Urogenital Diseases
- Male Urogenital Diseases
- Pathological Conditions, Anatomical
- Urologic Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urination Disorders
- Lower Urinary Tract Symptoms
- Urological Manifestations
- Urinary Incontinence
- Prolapse
- Pelvic Organ Prolapse
Other Study ID Numbers
- Women Pelvic Organ Prolapse
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.